Expression and significance of TGF-β1/Smad signaling pathway in children with IgA nephropathy

World Journal of Pediatrics

Volumn 5, Issue 3, 2009, Pages 211-215

  Wu, Wei ^a   Jiang, Xiao Yun ^a   Zhang, Qiao Ling ^a   Mo, Ying ^a   Sun, Liang Zhong ^a   Chen, Shu Mei ^a  

^a SUN YAT SEN UNIVERSITY   (China)

Author keywords

Glomerulonephritis; IgA nephropathy; Smad protein; Transforming growth factor

Indexed keywords

ALBUMIN; FIBRONECTIN; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; GLOMERULUS; HEMATURIA; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN A NEPHROPATHY; KIDNEY BIOPSY; KIDNEY FIBROSIS; KIDNEY PARENCHYMA; KIDNEY TUBULE; MALE; NEPHRITIS; PROTEIN EXPRESSION; PROTEINURIA;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE PROGRESSION; FEMALE; FIBRONECTINS; GLOMERULONEPHRITIS, IGA; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; IMMUNOGLOBULIN A; MALE; SMAD PROTEINS; SMAD3 PROTEIN; SMAD7 PROTEIN; TRANSFORMING GROWTH FACTOR BETA1;

EID: 69249200598     PISSN: 17088569     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12519-009-0040-3     Document Type: Article

References (12)

1. Coppo R. Pediatric IgA nephropathy: Clinical and therapeutic perspectives. Semin Nephrol 2008;28:18-26.
2. Yata N, Nakanishi K, Shima Y, Togawa H, Obana M, Sako M, et al. Improved renal survival in Japanese children with IgA nephropathy. Pediatr Nephrol 2008;23:905-912.
3. Guo B, Koya D, Isono M, Sugimoto T, Kashiwagi A, Haneda M. Peroxisome proliferator-activated receptor-gamma ligands inhibit TGF-beta 1-induced fibronectin expression in glomerular mesangial cells. Diabetes 2004;53:200-208.
4. The Subspecialty Group of Nephrology, Chinese Society of Pediatrics. Clinical classification, diagnosis and treatment of glomerular disease in children. Chin J Pediatr 2001;39:746-749.
5. Schena FP. IgA Nephropathies. In: Cameron JS, Davison AM, eds. Oxford Textbook of Clinical Nephrology. Vol I, 1st ed. Oxford: Oxford University Press, 1992: 339-369.
6. Katafuchi R, Kiyoshi Y, Oh Y, Uesugi N, Ikeda K, Yanase T, et al. Glomerular score as a prognosticator in IgA nephropathy: Its usefulness and limitation. Clin Nephrol 1998;49:1-8.
7. de Larco JE, Todaro GJ. Growth factors from murine sarcoma virus-transformed cells. Proc Natl Acad Sci U S A 1978;75:4001-4005.
8. Banas MC, Parks WT, Hudkins KL, Banas B, Holdren M, Iyoda M, et al. Localization of TGF-beta signaling intermediates Smad2, 3, 4, and 7 in developing and mature human and mouse kidney. J Histochem Cytochem 2007;55:275-285.
9. Yamamoto T, Noble NA, Cohen AH, Nast CC, Hishida A, Gold LI, et al. Expression of transforming growth factorbeta isoforms in human glomerular diseases. Kidney Int 1996;49:461-469.
10. Ruan Y, Zhang Z, Zhang X, Liu C, Guo M. The expressions of TGF-beta1 and Smad2 mRNA on diseased glomeruli and their significance in the development of glomerulosclerosis. Zhonghua Bing Li Xue Za Zhi 2002;31:314-317. [In Chinese]
11. Chen R, Huang C, Morinelli TA, Trojanowska M, Paul RV. Blockade of the effects of TGF-beta1 on mesangial cells by overexpression of Smad7. J Am Soc Nephrol 2002;13:887-893.
12. Schnaper HW, Hayashida T, Poncelet AC. It's a Smad world: Regulation of TGF-beta signaling in the kidney. J Am Soc Nephrol 2002;13:1126-1128.